P-162 Atezolizumab and bevacizumab pre-liver transplantation for patients with hepatocellular carcinoma beyond Milan criteria: Abstract Book of the ESMO 24th World Congress on Gastrointestinal Cancer 2022, Barcelona, Spain, 29 June -2 July 2022

M. Abdelrahim; G. OKane; A. Esmail; A. Saharia; S. Kodali; D. Victor

doi:10.1016/j.annonc.2022.04.252

P-162 Atezolizumab and bevacizumab pre-liver transplantation for patients with hepatocellular carcinoma beyond Milan criteria: Abstract Book of the ESMO 24th World Congress on Gastrointestinal Cancer 2022, Barcelona, Spain, 29 June -2 July 2022

M. Abdelrahim, G. OKane, A. Esmail, A. Saharia, S. Kodali, D. Victor

Research output: Contribution to journal › Article › peer-review

Original language	English (US)
Pages (from-to)	S308
Journal	Annals of Oncology
Volume	33
DOIs	https://doi.org/10.1016/j.annonc.2022.04.252
State	Published - 2022

Divisions

Abdominal Transplant
Gastroenterology and Hepatology
Medical Oncology

Access to Document

10.1016/j.annonc.2022.04.252

https://www.sciencedirect.com/science/article/pii/S0923753422009425

Cite this

Abdelrahim, M., OKane, G., Esmail, A., Saharia, A., Kodali, S., & Victor, D. (2022). P-162 Atezolizumab and bevacizumab pre-liver transplantation for patients with hepatocellular carcinoma beyond Milan criteria: Abstract Book of the ESMO 24th World Congress on Gastrointestinal Cancer 2022, Barcelona, Spain, 29 June -2 July 2022. Annals of Oncology, 33, S308. https://doi.org/10.1016/j.annonc.2022.04.252

P-162 Atezolizumab and bevacizumab pre-liver transplantation for patients with hepatocellular carcinoma beyond Milan criteria: Abstract Book of the ESMO 24th World Congress on Gastrointestinal Cancer 2022, Barcelona, Spain, 29 June -2 July 2022. / Abdelrahim, M.; OKane, G.; Esmail, A. et al.
In: Annals of Oncology, Vol. 33, 2022, p. S308.

Research output: Contribution to journal › Article › peer-review

Abdelrahim, M, OKane, G, Esmail, A , Saharia, A , Kodali, S & Victor, D 2022, 'P-162 Atezolizumab and bevacizumab pre-liver transplantation for patients with hepatocellular carcinoma beyond Milan criteria: Abstract Book of the ESMO 24th World Congress on Gastrointestinal Cancer 2022, Barcelona, Spain, 29 June -2 July 2022', Annals of Oncology, vol. 33, pp. S308. https://doi.org/10.1016/j.annonc.2022.04.252

Abdelrahim M, OKane G, Esmail A , Saharia A , Kodali S, Victor D. P-162 Atezolizumab and bevacizumab pre-liver transplantation for patients with hepatocellular carcinoma beyond Milan criteria: Abstract Book of the ESMO 24th World Congress on Gastrointestinal Cancer 2022, Barcelona, Spain, 29 June -2 July 2022. Annals of Oncology. 2022;33:S308. doi: 10.1016/j.annonc.2022.04.252

@article{876bdbf5829646fba133481791074bbb,

title = "P-162 Atezolizumab and bevacizumab pre-liver transplantation for patients with hepatocellular carcinoma beyond Milan criteria: Abstract Book of the ESMO 24th World Congress on Gastrointestinal Cancer 2022, Barcelona, Spain, 29 June -2 July 2022",

author = "M. Abdelrahim and G. OKane and A. Esmail and A. Saharia and S. Kodali and D. Victor",

year = "2022",

doi = "10.1016/j.annonc.2022.04.252",

language = "English (US)",

volume = "33",

pages = "S308",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Elsevier Ltd",

}

TY - JOUR

T1 - P-162 Atezolizumab and bevacizumab pre-liver transplantation for patients with hepatocellular carcinoma beyond Milan criteria

T2 - Abstract Book of the ESMO 24th World Congress on Gastrointestinal Cancer 2022, Barcelona, Spain, 29 June -2 July 2022

AU - Abdelrahim, M.

AU - OKane, G.

AU - Esmail, A.

AU - Saharia, A.

AU - Kodali, S.

AU - Victor, D.

PY - 2022

Y1 - 2022

U2 - 10.1016/j.annonc.2022.04.252

DO - 10.1016/j.annonc.2022.04.252

M3 - Article

SN - 0923-7534

VL - 33

SP - S308

JO - Annals of Oncology

JF - Annals of Oncology

ER -